Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance

• Kamran Kaveh ,

  * E-mail: kkavehma@gmail.com (KK); shui@coh.org (SKH)

  Affiliation Program for Evolutionary Dynamics, Harvard University, Cambridge, Massachusetts, United States of America

  http://orcid.org/0000-0002-8213-1797

  ⨯
• Yutaka Takahashi,

  Affiliations Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota, United States of America, Department of Radiation Oncology, Osaka University, Osaka, Japan

  ⨯
• Michael A. Farrar,

  Affiliation Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, United States of America

  http://orcid.org/0000-0002-5569-0366

  ⨯
• Guy Storme,

  Affiliation Department of Radiotherapy, Universitair Ziekenhuis Brussel, Brussels, Belgium

  ⨯
• Marcucci Guido,

  Affiliation Department of Hematology and Beckman Research Institute, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Jamie Piepenburg,

  Affiliation Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota, United States of America

  http://orcid.org/0000-0002-8067-8510

  ⨯
• Jackson Penning,

  Affiliation Department of Mathematics, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Jasmine Foo,

  Affiliation Department of Mathematics, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Kevin Z. Leder,

  Affiliation Industrial and Systems Engineering, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Susanta K. Hui

  * E-mail: kkavehma@gmail.com (KK); shui@coh.org (SKH)

  Affiliations Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota, United States of America, Department of Radiation Oncology, City of Hope National Medical Center and Beckman Research Institute, Duarte, California, United States of America

  ⨯